CTC (Chicago Trading Company)
REGN icon

CTC (Chicago Trading Company)’s Regeneron Pharmaceuticals REGN Stock Holding History

CTC (Chicago Trading Company)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,349
Closed -$422K – 27
2013
Q3 		$422K Buy
+1,349
New +$355K 0.01% 18

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CTC (Chicago Trading Company)'s REGN Position: Q4 2013 in Review

CTC (Chicago Trading Company) sold out of Regeneron Pharmaceuticals (REGN) in Q4 2013, closing a stake of 1,349 shares — an estimated $422K sold.

CTC (Chicago Trading Company) first reported a position in REGN in Q3 2013 and held it in 1 quarter. The position peaked at $422K in Q3 2013. 438 funds tracked by Wall St. Rank hold REGN as of Q4 2013.

  • CTC (Chicago Trading Company) reported no remaining Regeneron Pharmaceuticals position as of Q4 2013 after selling out during the quarter.
  • CTC (Chicago Trading Company) sold 1,349 Regeneron Pharmaceuticals shares in Q4 2013, an estimated $422K.
  • CTC (Chicago Trading Company) first reported a position in Regeneron Pharmaceuticals in Q3 2013 and held it in 1 quarter.
  • CTC (Chicago Trading Company)'s Regeneron Pharmaceuticals position peaked at $422K in Q3 2013.
  • 438 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2013.

Based on CTC (Chicago Trading Company)'s 13F filing for Q4 2013, filed 31 Jan 2014.